Covered recipient · General Payments record
NATALIA PAOLA HERNANDEZ
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$1,900.02
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,536.98 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $972.15 | 18 |
| Gilead Sciences, Inc. | $162.27 | 2 |
| Olympus Latin America, Inc. | $124.95 | 1 |
| Janssen Biotech, Inc. | $117.34 | 1 |
| Janssen Pharmaceuticals, Inc | $65.27 | 2 |
| E.R. Squibb & Sons, L.L.C. | $50.00 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910088 | CMS |
| ABBVIE INC. | $27.11 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910090 | CMS |
| ABBVIE INC. | $26.75 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910092 | CMS |
| ABBVIE INC. | $25.00 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910094 | CMS |
| ABBVIE INC. | $23.90 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910096 | CMS |
| ABBVIE INC. | $25.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910098 | CMS |
| ABBVIE INC. | $125.00 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910100 | CMS |
| ABBVIE INC. | $124.99 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910102 | CMS |
| ABBVIE INC. | $124.95 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910104 | CMS |
| ABBVIE INC. | $25.00 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910106 | CMS |
| ABBVIE INC. | $29.58 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910108 | CMS |
| ABBVIE INC. | $25.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910110 | CMS |
| ABBVIE INC. | $91.88 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910112 | CMS |
| ABBVIE INC. | $25.00 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910114 | CMS |
| ABBVIE INC. | $66.37 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910116 | CMS |
| ABBVIE INC. | $125.37 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910118 | CMS |
| ABBVIE INC. | $25.00 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910120 | CMS |
| ABBVIE INC. | $26.25 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103910122 | CMS |
| Boston Scientific Corporation | $20.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092236396 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101514540 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101514571 | CMS |
| Gilead Sciences, Inc. | $50.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133750366 | CMS |
| Gilead Sciences, Inc. | $112.27 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133750368 | CMS |
| Janssen Biotech, Inc. | $117.34 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078614943 | CMS |
| Janssen Pharmaceuticals, Inc | $40.27 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078171179 | CMS |
| Janssen Pharmaceuticals, Inc | $25.00 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078172021 | CMS |
| Olympus Latin America, Inc. | $124.95 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099612479 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.00 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137575282 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.